Istiratumab
Product Specifications
CAS Number
1509928-04-4
Target
IGF-1R, EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
Istiratumab (M-6495), a bispecific monoclonal antibody, targets IGF-1R and ErbB3 receptors and facilitates their degradation via the proteasome pathway, offering potential for cancer research [1] [2] [3].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1059725-01 0.02 mg (E-Coli)
Recombinant Schizosaccharomyces pombe NEDD8-specific protease 1 (nep1)
Sign In for Pricing
View Details MBS1059725-02 0.02 mg (Yeast)
Recombinant Schizosaccharomyces pombe NEDD8-specific protease 1 (nep1)
Sign In for Pricing
View Details MBS1059725-03 0.1 mg (E-Coli)
Recombinant Schizosaccharomyces pombe NEDD8-specific protease 1 (nep1)
Sign In for Pricing
View Details MBS1059725-04 0.1 mg (Yeast)
Recombinant Schizosaccharomyces pombe NEDD8-specific protease 1 (nep1)
Sign In for Pricing
View Details MBS1059725-05 0.02 mg (Baculovirus)
Recombinant Schizosaccharomyces pombe NEDD8-specific protease 1 (nep1)
Sign In for Pricing
View Details MBS1059725-06 0.02 mg (Mammalian-Cell)
Recombinant Schizosaccharomyces pombe NEDD8-specific protease 1 (nep1)
Sign In for Pricing
View Details